Therapeutic and diagnostic developers gain flexibility, speed, and scalability to advance custom formulations from preclinical research to manufacturing for clinical trials, with a reviewed quote returned in under three business days HOLLISTER, Calif. — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, […]
Collaboration combines Tamarind Bio’s AI-powered molecular design platform with GenScript’s wet-lab capabilities to help researchers move from digital concepts to experimental proof PISCATAWAY, N.J. and SAN FRANCISCO — Artificial intelligence can now generate thousands of potential drug molecules in the time it once took to design one, dramatically expanding what scientists can imagine. Yet deciding […]
New CONOSTAN ASTM D3606 method standards range covers the complete GC analysis workflow AnalytiChem’s new CONOSTAN® ASTM D3606 standards range ensures complete confidence in benzene and toluene content testing in fuels by GC. Eschborn, Germany — AnalytiChem, manufacturer of specialized chemicals, reagents, accredited standards, equipment and consumables, has introduced a new range of CONOSTAN® Gas Chromatography […]
FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies Paris, France — DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million […]
The phenol-free magnetic bead workflow includes DNase treatment to optimize cfRNA recovery for downstream sequencing and amplification IPSWICH, Mass. — New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit, which enables isolation of low-abundance, circulating cell-free RNA (cfRNA) and exome-associated RNA from biofluids including plasma, serum, urine and […]
Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]
WALTHAM, Mass. Key Facts Thermo Scientific™ X2 and S2 Series General Purpose Centrifuges enable labs to improve sustainability without compromising performance. X2 and S2 Centrifuges deliver high performance in a smaller, more versatile format for medical research, biopharma and clinical labs. Additional benefits: Improved sustainability through a low-GWP natural refrigerant system and more energy efficiency […]
TORRANCE, CA, – Phenomenex Inc., a Danaher company and global leader in advanced technologies for the separation sciences, today announced the appointment of Dr. Lauryn Bailey as President of Phenomenex. Dr. Bailey joined Phenomenex in 2022 and has played an important role in advancing the company’s commercial and strategic priorities. “I’m honored to lead Phenomenex and […]
Stockholm-based service provider adds Evercode to its single cell sequencing offerings SEATTLE — Parse Biosciences, the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics has joined its Certified Service Provider (CSP) program, becoming the first in the Nordic region. The Stockholm-based company will offer Parse’s Evercode single cell […]
Agreement marks the start of Eppendorf’s planned manufacturing facility in Penang Eppendorf will invest EUR 40 million in the site, with production expected to start in 2028 New facility will produce selected products of the Centrifuges & Instruments portfolio for global laboratory markets Penang, Malaysia – Eppendorf has signed an agreement for a new production […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
